Cargando…
Preventing β-amyloid fibrillization and deposition: β-sheet breakers and pathological chaperone inhibitors
Central to the pathogenesis of Alzheimer's disease (AD) is the conversion of normal, soluble β-amyloid (sAβ) to oligomeric, fibrillar Aβ. This process of conformational conversion can be influenced by interactions with other proteins that can stabilize the disease-associated state; these protei...
Autores principales: | Wisniewski, Thomas, Sadowski, Martin |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2008
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2604889/ https://www.ncbi.nlm.nih.gov/pubmed/19090993 http://dx.doi.org/10.1186/1471-2202-9-S2-S5 |
Ejemplares similares
-
Feasibility of β-Sheet Breaker Peptide-H102 Treatment for Alzheimer's Disease Based on β-Amyloid Hypothesis
por: Lin, Lai-xiang, et al.
Publicado: (2014) -
Consecutive Aromatic Residues Are Required for Improved Efficacy of β-Sheet Breakers
por: Jarmuła, Adam, et al.
Publicado: (2022) -
The Amyloid Fibril-Forming β-Sheet Regions of Amyloid β and α-Synuclein Preferentially Interact with the Molecular Chaperone 14-3-3ζ
por: Williams, Danielle M., et al.
Publicado: (2021) -
Nanomedicine against Aβ Aggregation by β–Sheet Breaker Peptide Delivery: In Vitro Evidence
por: Pederzoli, Francesca, et al.
Publicado: (2019) -
Bicine promotes rapid formation of β-sheet-rich amyloid-β fibrils
por: Kim, Hye Yun, et al.
Publicado: (2020)